The mitotic spindle assembly checkpoint ensures proper chromosome segregation during mitosis by inhibiting the onset of anaphase until all kinetochores are attached to the mitotic spindle and tension across the kinetochores is generated. Here, we report that the stable partial downregulation of the spindle checkpoint gene MAD1, which is observed in human cancer, leads to a functional inactivation of the spindle checkpoint resulting in gross aneuploidy. Interestingly, although Mad1 is thought to act as a kinetochore based activator of Mad2 during checkpoint activation, we show that normal levels of Mad2, but not of Mad1, are required for preventing premature sister chromatid separation and for maintaining the timing of an undisturbed mitosis, suggesting a Mad1 independent function of Mad2 that operates independent of its checkpoint function. Most significantly, a partial repression of either MAD1 or MAD2 confers resistance to nocodazole, a drug that inhibits microtubule attachment. In contrast, sensitivity to clinically relevant drugs like taxol or monastrol that inhibit the generation of tension across kinetochores is not modulated by partial downregulation of MAD1, suggesting a functional bifurcation of spindle checkpoint dependent apoptotic pathways.
Introduction
The faithful segregation of chromosomes during mitosis requires that all chromosomes are correctly attached to the mitotic spindle apparatus and properly aligned at the metaphase plate before anaphase onset is allowed. During the early phases of mitosis when chromosomes are not yet aligned, the mitotic spindle assembly checkpoint is activated (Campbell and Gorbsky, 1995; Li and Nicklas, 1995; Rieder et al., 1995) and prevents the onset of anaphase by inhibiting the anaphase promoting complex/cyclosome (APC/C) (Li et al., 1997; Fang et al., 1998; Gorbsky et al., 1998) . This large ubiquitin ligase complex is required for the ubiquitination and destruction of securin and cyclin B, prerequisites for anaphase onset and mitotic exit, respectively (for a review see Peters, 2002) . The spindle checkpoint is also activated in response to various spindle poisons like nocodazole, a drug that depolymerizes microtubules, and thus, prevents the attachment of microtubules to the kinetochores. On the other hand, anticancer drugs, like taxanes (e.g. paclitaxel/taxol), inhibit the dynamic instability of the spindle and allow microtubule attachment, but prevent the generation of tension across kinetochores. Treatment of cells with these drugs inhibits chromosome alignment and results in a mitotic arrest before anaphase, which is followed by the induction of apoptosis (Jordan and Wilson, 2004) .
To date, the molecular pathways of the spindle checkpoint are not well understood, but it is established that several evolutionary conserved proteins including Cenp-E, BubR1, Bub1, Bub3, Mad1, Mad2 and Mps1 are required for spindle checkpoint function (for a review see Yu, 2002; Bharadwaj and Yu, 2004; Taylor et al., 2004) . These and most likely additional yet unknown proteins are sequentially recruited to unattached or tension-lacking kinetochores leading to the generation of a diffusible APC/C inhibitor (Shah and Cleveland, 2000; Musacchio and Hardwick, 2002; Vigneron et al., 2004) . Mad2, BubR1, and also a mitotic checkpoint complex (MCC) consisting of Mad2, BubR1, Bub3 and Cdc20 can function as potent inhibitors for APC/C activity, but the mechanism of the MCC formation is still unclear (Fang et al., 1998; Sudakin et al., 2001; Tang et al., 2001; Fang, 2002) . According to a current model, an unattached kinetochore serves as an activating platform for the diffusible APC/C inhibitor. Consistently, Mad1 is required for recruitment of Mad2 to kinetochores and complex formation of Mad1 and Mad2 at the kinetochore is important for checkpoint activation, suggesting that Mad1 might function as an activator of Mad2 at the kinetochore (Jin et al., 1998; Chen et al., 1999; Campbell et al., 2001; Sironi et al., 2001; Luo et al., 2002; MartinLluesma et al., 2002) .
Interestingly, Mad2 and BubR1 appear to be also involved in regulating the normal timing of mitosis. Inhibition of Mad2 or BubR1, but none of the other Mad and Bub proteins, causes an acceleration of mitosis (Gorbsky et al., 1998; Canman et al., 2002; Meraldi et al., 2004) . Moreover, the inhibition of their kinetochore localization does not shorten the time from prophase to anaphase indicating that Mad2 and BubR1 might be part of a kinetochore independent mitotic timer mechanism (Meraldi et al., 2004) .
The majority of human cancer cells are aneuploid, which can be caused by gaining or loosing whole chromosomes during defective chromosome segregation events (Duesberg et al., 2000; Sieber et al., 2003) . This phenotype is called chromosomal instability (CIN) and although its molecular basis is still unknown, it is now apparent that malfunction of the spindle checkpoint can directly contribute to CIN Michel et al., 2001; Masuda and Takahashi, 2002; Babu et al., 2003; Rajagopalan and Lengauer, 2004) . Indeed, defects in the spindle checkpoint are frequently found in various types of human cancer including lung, breast, ovarian, colon and hepatocellular tumors and these defects are associated with CIN and aneuploidy (Cahill et al., 1998; Takahashi et al., 1999; Masuda and Takahashi, 2002; Shichiri et al., 2002) . While spindle checkpoint defects are frequent, spindle checkpoint genes appear to be rarely altered in human tumors (Cahill et al., 1998; Nomoto et al., 1999; Hernando et al., 2001) . Instead, downregulated expression of spindle checkpoint genes might contribute to a deactivated spindle checkpoint in cancer cells. In fact, the genes of the MCC, MAD2, BUB3 and BUBR1, have been shown to be haploinsufficient (Michel et al., 2001; Babu et al., 2003; Baker et al., 2004) . Heterozygous deletion of MAD2 in human colon carcinoma cells and heterozygous MAD2, BUB3 or BUBR1 disruptions in mice result in partially downregulated checkpoint protein levels, an impaired spindle checkpoint and aneuploidy (Michel et al., 2001; Babu et al., 2003; Baker et al., 2004) . Most significantly, MAD2
þ /À and BUBR1 þ /À mice are prone to tumor development suggesting that aneuploidy can contribute directly to tumorigenesis (Michel et al., 2001; Babu et al., 2003; Dai et al., 2004) . To date, it is unclear if a moderate downregulation of other spindle checkpoint genes directly contributes to aneuploidy and tumorigenesis; however, a reduced expression of MAD2 and BUBR1, but also of BUB1 and MAD1, has been found in different human cancers (Li and Benezra, 1996; Shichiri et al., 2002; Wang et al., 2002) . Surprisingly, spindle checkpoint defects have recently been associated with resistance to spindle damaging anticancer drugs, for example, paclitaxel/taxol (Kasai et al., 2002; Anand et al., 2003; Masuda et al., 2003; Sudo et al., 2004) and with the resistance to topoisomerase poisons, for example, etoposide, adriamycin/ doxorubicin (Vogel et al., 2004b) . These findings indicate that the spindle checkpoint might be directly involved in the induction of apoptosis upon mitotic damage and imply that tumors harboring a compromised spindle checkpoint are resistant to such chemotherapeutic treatments. However, the molecular mechanisms of the crosstalk between the spindle checkpoint and apoptotic pathways remain to be determined.
A function of Mad1 together with Mad2 for the spindle checkpoint has been demonstrated in cells depleted of Mad1 by transient siRNA transfections (Luo et al., 2002; Martin-Lluesma et al., 2002; Meraldi et al., 2004) . However, severe depletion or homozygous disruption of spindle checkpoint genes results in cell death indicating that spindle checkpoint genes are essential for viability (Dobles et al., 2000; Kalitsis et al., 2000; Kops et al., 2004; Michel et al., 2004) . Therefore, previous studies could not address the longterm physiological consequences of Mad1 inactivation. Moreover, in human cancer, only partial downregulation of MAD1 or MAD2 is observed and it is important to resolve whether a partial downregulation of MAD1 or MAD2 is functionally redundant. Therefore, we investigated the phenotypes associated with partial downregulation of MAD1 or MAD2. Our results indicate a differential requirement of Mad1 and Mad2 for spindle checkpoint activation, mitotic timing and induction of apoptosis in response to chemotherapeutic drugs in human cancer cells.
Results

Generation of human colon carcinoma cells exhibiting reduced levels of Mad1
We wished to generate karyotypically stable human cells exhibiting partial downregulation of MAD1. For this, we stably expressed an siRNA targeting MAD1 in HCT116 cells, which are well characterized for their intact cell cycle checkpoints and their relatively stable karyotype. In addition, HCT116 cells have been used previously for heterozygous gene deletion of MAD2 (HCT116-MAD2 þ /À ) resulting in cells with approximately 20% reduction of Mad2 protein level (Michel et al., 2001) . This enabled us to investigate and to compare the long-term cellular consequences of MAD1 and MAD2 downregulation. Upon stable transfection we selected two independent clones, termed knockdown clone 2-2 (MAD1-kd-2-2) and knockdown clone 2-31 (MAD1-kd-2-31) for the experiments throughout this study. These clones showed about 35 and 50% reduction of endogenous Mad1 protein, respectively, when compared to HCT116-wild-type cells (HCT116-wt) and to puromycin resistant control cells (HCT116-pSUPER) as shown on Western blots using specific anti-Mad1 antibodies ( Figure 1a ). When grown asynchronously in culture, HCT-MAD1-kd cells did not show significant changes in cell cycle distribution, proliferation rate or apoptosis indicating that a repression of MAD1 is neither affecting the cell cycle timing per se nor causing lethality (Figure 1b ).
Partial downregulation of MAD1 or MAD2 result in a defective spindle checkpoint
To investigate whether a partial downregulation of MAD1 would account for a defective spindle assembly checkpoint function, we determined the mitotic arrest in response to nocodazole, which prevents microtubule attachment to the kinetochores, and thus, chromosome alignment ( Figure 2a ). Both MAD1-kd cell lines (2-2 and 2-31) showed a mitotic index with maximum values of 30-40% similar to that observed in HCT-MAD2 þ /À cells. In contrast, a maximum of approximately 70% of the wild type and control cells accumulated in mitosis. Further, isogenic p53 deficient cells (HCT-p53 À/À ) arrested like wild-type cells indicating no requirement of p53 for normal spindle checkpoint function. Very similar results were observed after treatment with taxol or monastrol, drugs that inhibit the spindle dynamics and the formation of a bipolar spindle, respectively, allowing microtubule attachment, but not the generation of tension (Figure 2b and c) . Our results clearly demonstrate that partial downregulation of either MAD1 or MAD2 results in a very similar functional inactivation of the spindle checkpoint in response to lack of microtubule attachment and upon lack of tension across kinetochores.
Consistently, the defect in spindle checkpoint activation in HCT-MAD1-kd and HCT-MAD2 þ /À cells was accompanied by a premature exit from mitosis in the presence of nocodazole. This was demonstrated by the premature degradation of cyclin B (Figure 2d ) and by generation of multinuclei around groups of chromosomes ( Figure 2e ). Quantification of multinuclei revealed that after 18 h of spindle damage 60-65% of both, MAD1-kd cells and HCT-MAD2 þ /À cells, had exited without cytokinesis whereas only 3-8% of the control cells had formed multinuclei after 18 h of nocodazole treatment ( Figure 2e ). Under these conditions, the multinuclei contained a tetraploid DNA content as demonstrated by FACS analyses (Figure 2f ). Furthermore, the premature exit from mitosis in spindle checkpoint deficient cells resulted in a similar high rate of endoreduplication in MAD1-kd and HCT-MAD2
þ /À cells (data not shown; Vogel et al., 2004a) . Taken together, partial downregulation of either MAD1 or MAD2 results in a very similar functional inactivation of the spindle checkpoint.
Reduced levels of MAD2 but not of MAD1 induce a high rate of premature sister chromatid segregation Spindle checkpoint inhibition is expected to result in premature sister chromatid separation. To test whether partial downregulation of MAD1 or MAD2 results in premature sister chromatid segregation, we performed metaphase chromosome spread analyses ( Figure 3a ) and determined the proportion of cells showing disjoined sister chromatids (Figure 3b ). Upon a 2-h nocodazole treatment, HCT-MAD2 þ /À cells displayed a high rate of premature anaphases (11-15%) demonstrating, in agreement with previous findings (Michel et al., 2001) , that normal levels of Mad2 are required to prevent gross premature sister chromatid separation. Upon prolonged nocodazole treatment (6 h), the proportion was even increased to 16-21%. In contrast, both MAD1-kd cell lines showed much lower proportions of premature anaphases after 2 and 6 h treatment (2.1-3.3% and 3-5%, respectively) corresponding to just about 20% of the rate observed in HCT-MAD2 þ /À cells ( Figure 3b ). Our findings suggest the premature sister chromatid separation might be restrained by a Mad1 independent function of Mad2.
Normal levels of Mad2 but not of Mad1 are required for normal mitotic timing Previous studies have indicated that the spindle checkpoint regulates the timing of a normal mitosis in the absence of damage (Taylor and McKeon, 1997; Gorbsky et al., 1998; Shannon et al., 2002; Meraldi et al., 2004) . Moreover, a kinetochore independent function of Mad2 and BubR1, but not of other Mad or Bub proteins, appears to be required for the mitotic timer function (Meraldi et al., 2004) . Therefore, we investigated whether partial downregulation of MAD1 or MAD2, which is observed in human cancer, might disturb the normal timing of mitosis. We treated asynchronously growing HCT-MAD1-kd, HCT-MAD2 þ /À and control cells with the proteasome inhibitor ALLN for up to 3 h to block mitotic progression beyond metaphase in the absence of spindle damage and determined the proportion of metaphase figures (Figure 4) . All cell lines exhibit similar growth rates and similar rates of mitotic entry without the addition of ALLN (DMSO control). As expected, ALLN treatment increased the proportion of metaphases in control cells to 35-38%, indicating that the mitotic progression is indeed blocked by proteasome inhibition. In contrast, in HCT-MAD2 þ /À cells metaphases were increased to 62-64% indicating an acceleration of þ /À , HCT-MAD1 knockdown and control cells were treated with the proteasome inhibitor ALLN for 3 h to block mitotic progression beyond metaphase or with DMSO as a control. Cells were fixed, DNA was stained with Hoechst dye and mitotic figures were counted. The proportion of metaphases was calculated and the graph shows mean values and standard deviations from three independent experiments. At least 1800 mitotic figures were counted per cell line þ /À cells and two independent HCT-MAD1 knockdown cell lines (2-2 and 2-31) were used for chromosome spread analyses and individual chromosomes were counted. The distribution of chromosome numbers is shown and the percentage of aneuploidy was calculated (45 chromosomes represent the relative euploid karyotype of HCT116 cells). At least 150 metaphase spreads were counted for each cell line aneuploidy). In agreement with previous findings (Michel et al., 2001) , we found HCT-MAD2 þ /À cells to be similarly aneuploid (55% aneuploidy). Thus, the prevention of aneuploidy requires normal levels of both, Mad1 and Mad2.
Tumor cells exhibiting reduced levels of MAD2, but not of MAD1 are resistant to taxol treatment Spindle damaging agents are clinically highly relevant anticancer drugs (Jordan and Wilson, 2004) . Interestingly, defects in the spindle checkpoint have been recently associated with a resistance to these chemotherapeutic drugs (Kasai et al., 2002; Anand et al., 2003; Masuda et al., 2003; Sudo et al., 2004) . However, it is largely unknown how apoptosis is induced in response to these treatments and what the parameters are that determine sensitivity or resistance to spindle poisons. Therefore, we investigated the induction of apoptosis in HCT-wt, HCT-p53
þ /À and HCT-MAD1-kd cells in response to a treatment with drugs that either inhibit microtubule attachment (nocodazole; Figure 6 , left panels) or that prevent the generation of tension across kinetochores (taxol and monastrol; Figure 6 , middle and right panels). The induction of apoptosis was monitored by the detection of the apoptosis specific laddering of chromosomal DNA (Figure 6a) , by the detection of the apoptosis specific cleavage product of poly-(ADP-ribose)-polymerase (PARP; Figure 6b ) and by quantifying the activity of caspase-3 in whole cells (Figure 6c ). All three independent assays consistently show that both spindle checkpoint compromised cell lines efficiently escape from apoptosis upon treatment with nocodazole, that is, in response to the lack of microtubule attachment ( Figure 6 , left panels). Significantly and in contrast to Further, we found that HCT116-p53 À/À escape from apoptosis after nocodazole, taxol or monastrol treatments indicating a general requirement of p53 for the induction of apoptosis in response to spindle damage. Thus, our findings clearly demonstrate that the status of the spindle checkpoint per se does not determine the sensitivity towards spindle targeting chemotherapeutic drugs, but rather the status of individual spindle checkpoint components. In fact, our results suggest a Mad1 independent function of Mad2 to be required for the taxol induced apoptosis and a functional bifurcation for the induction of apoptosis depending on the nature of spindle damage.
Discussion
Our data presented here establish the following main points. (i) A stable partial downregulation of either MAD1 or MAD2, similar to the situation observed in human cancer cells, is sufficient to cause a functional inactivation of the mitotic spindle assembly checkpoint in response to the lack of microtubule attachment or upon the lack of tension across the kinetochores. Most importantly, this phenotype is associated with the generation of gross aneuploidy. (ii) Normal expression of MAD2, but not of MAD1, is required to prevent premature sister chromatid separation during checkpoint activation. (iii) Partial repression of MAD2, but not of MAD1, causes an acceleration of normal mitotic timing. (iv) Partial downregulation of either MAD2 or MAD1 confers resistance to spindle-damaging agents that disrupt the microtubule-kinetochore attachment. In contrast, reduced levels of Mad2, but not of Mad1, lead to resistance to chemotherapeutic drugs that inhibit the generation of tension, for example, paclitaxel/taxol.
Partial downregulation of spindle checkpoint in human cancer
Obvious candidate genes that might be involved in causing CIN in cancer are the spindle checkpoint genes, but these appear to be rarely inactivated by mutation in human cancer (Cahill et al., 1998; Nomoto et al., 1999; Takahashi et al., 1999; Hernando et al., 2001; Masuda and Takahashi, 2002) . However, partial downregulation of spindle checkpoint genes including MAD1, MAD2, BUB1 and BUBR1 has been observed in cancer cells (Li and Benezra, 1996; Shichiri et al., 2002; Wang et al., 2002) . In fact, experimental partial repression of MAD2 leads to spindle checkpoint inactivation (Wang et al., 2002) and causes aneuploidy (Michel et al., 2001 ; and this study). Similarly, reduced expression of BUBR1 or BUB3 in heterozygous mice (Babu et al., 2003; Baker et al., 2004; Dai et al., 2004) , or of MAD1 in human somatic cells (this study) is sufficient to cause spindle checkpoint inactivation and aneuploidy indicating that normal expression of the spindle checkpoint genes is essential for mediating mitotic arrest in response to spindle damage and for maintaining chromosomal stability. It is important to note that severe downregulation, disruption or homozygous mutational inactivation of spindle checkpoint genes appears to be incompatible with survival (Dobles et al., 2000; Kalitsis et al., 2000; Kops et al., 2004; Michel et al., 2004) , which might explain why only partial downregulation of spindle checkpoint genes is observed in human cancer.
mice, the spindle checkpoint inactivation is also associated with enhanced tumor development (Michel et al., 2001; Babu et al., 2003; Dai et al., 2004) , suggesting that aneuploidy can directly contribute to tumorigenesis. However, the mechanisms of cancer specific downregulation of spindle checkpoint gene expression are currently unknown. Interestingly, in human colorectal carcinomas of advanced clinical state, a significant silencing of mRNA expression of BUB1 and BUBR1 was observed, suggesting that epigenetic mechanisms like promotor methylation might account for reduced gene expression in cancer cells (Shichiri et al., 2002 ). Nevertheless, the expression level of spindle checkpoint genes is of great diagnostic value to predict spindle checkpoint activity and CIN.
Different phenotypes associated with the downregulation of MAD1 or MAD2
A number of previous studies have suggested that Mad1 acts as an activator of Mad2 at the checkpoint activated kinetochore (Sironi et al., 2001; Luo et al., 2002; MartinLluesma et al., 2002) . However, an elegant recent study has demonstrated a requirement of Mad2 and BubR1, but not of other checkpoint proteins for the normal timing of mitosis (Meraldi et al., 2004) . Further, this work proposed a cytosolic and kinetochore independent function of Mad2 and BubR1 during an undisturbed mitosis. Our data strongly support the idea of additional kinetochore and Mad1 independent functions of Mad2, which might be separable from its checkpoint function. Since partial downregulation of MAD1 neither accelerates mitosis nor significantly elevates the proportion of premature sister chromatid separation when compared to cells with reduced levels of Mad2, we suggest a Mad1 independent function of Mad2 not only for normal mitotic timing but also for preventing the premature onset of anaphase. According to this model, a cytosolic pool of Mad2 and BubR1 might be involved in preventing the APC/C-mediated proteolysis of securin, which is required for sister chromatid separation (Nasmyth et al., 2000) . This idea is further supported by similar observations that were made in BUB3
MEFs, where reduced expression of BUB3 leads to an impairment of the spindle checkpoint in response to spindle damage but not to an induction of premature sister chromatid segregation (Babu et al., 2003) . Interestingly, the model of separable functions of Mad1 and Mad2 might also explain the concomitant downregulation of MAD1 and MAD2 observed in ovarian carcinoma cells (Wang et al., 2002) .
Crosstalk of the mitotic spindle checkpoint and apoptotic pathways in response to chemotherapeutic treatment
Chemotherapeutic drugs that target the mitotic spindle, including taxanes and vinca alkaloids, are frequently used for treatment of lymphomas, ovarian, breast and lung tumors (Jordan and Wilson, 2004) . However, it is still unclear how these drugs induce apoptosis and what the molecular mechanisms of the resistance are. First reports have indicated that rapid drug export via ABC transporters, the status of bcl-2 or enhanced microtubule dynamics can confer resistance (Jordan and Wilson, 2004) . In addition, most recent reports have provided a strong correlation between the status of the spindle checkpoint and the susceptibility to spindle damaging agents (Kasai et al., 2002; Anand et al., 2003; Masuda et al., 2003; Sudo et al., 2004) . We have now established that the induction of apoptosis induced by drugs that abrogate the microtubule attachment (e.g. nocodazole) requires normal levels of both, Mad1 and Mad2. In contrast, partial downregulation of MAD1 does not confer resistance to agents that inhibit the microtubule dynamics and the generation of tension (e.g. taxol and monastrol), although it is clearly sufficient to cause spindle checkpoint inactivation suggesting an uncoupling of mitotic arrest and induction of apoptosis. Our results indicate that a Mad1 and possibly kinetochore independent function of Mad2 might also be involved in the induction of apoptosis in response to the lack of tension. However, the induction of apoptosis in response to the lack of attachment requires Mad1 and Mad2. These findings suggest a functional bifurcation of apoptotic pathways depending on the nature of spindle damage. Significantly, a functional bifurcation of the spindle checkpoint is also observed for the mitotic arrest. The chromosomal passenger proteins including Aurora B and survivin are required for a sustained arrest in response to the lack of tension, but not upon nocodazole treatment (Ditchfield et al., 2003; Hauf et al., 2003; Lens et al., 2003) . Interestingly, survivin has been shown to regulate directly the induction of apoptosis (Li et al., 1999) , which might reflect a possible link between the spindle checkpoint and the activation of apoptotic pathways. It will be important to elucidate what the molecular mechanisms are that mediate the induction of apoptosis under these different conditions. Since it is now recognized that the commonly used chemotherapeutic drugs like taxanes and vinca alkaloids mediate their death-inducing effects through the suppression of the microtubule dynamics rather than by depolymerization of the microtubules (Jordan and Wilson, 2004) , it seems likely that these drugs employ the Mad2 dependent, but Mad1 independent apoptotic pathway. Therefore, the status of Mad2 rather than of Mad1, and not the functionality of the spindle checkpoint in cancer cells per se, appears to be the important determinant to predict a resistance towards taxol or related chemotherapeutic drugs.
Materials and methods
Cell culture
HCT116-wild type, HCT116-p53
À/À and HCT116-MAD2
þ /À cells (Michel et al., 2001) were kindly provided by Bert Vogelstein (Baltimore, USA), Loren Michel and Robert Benezra (New York, USA), respectively. All HCT116 derivative cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum, 1% glutamine and 100 mg/ml streptomycin and 100 U/ml penicillin (all from Gibco, Netherlands) at 371C under 95% water and 5% CO 2 atmosphere. Where indicated cells were treated with 150 nM nocodazole (Sigma, Germany), 100 nM taxol (Sigma) or 70 mM monastrol (Sigma).
Generation of stable HCT116 MAD1 knockdown cell lines
A double-stranded oligonucleotide corresponding to nt992-1014 of the human MAD1 cDNA (5 0 -AAGACCTTTCCAGATT CGTGGTT-3 0 ) was cloned into the BglII-HindIII site of pSuper (Brummelkamp et al., 2002) . HCT116 cells were cotransfected with the pSuper construct and pBabe-puro using Superfect (Qiagen, Germany) following the manufacturer´s instructions. At 2 days post-transfection stable clones were selected in medium containing 5 mg/ml puromycin (Sigma). In total, 31 stable clones were tested for activation of the spindle assembly checkpoint by measuring the mitotic index 16 h after the addition of nocodazole or taxol. Two clones, termed 2-2 and 2-31 were selected and used for further experiments throughout this study.
Western blotting
Western blotting was performed as described (Vogel et al., 2004a) using the following antibodies: monoclonal anti-Mad1 (a generous gift from Dr TJ Yen, Philadephia, USA), antiactin (Sigma), anti-cyclin B (H-433, Santa Cruz, USA), anti-PARP (BD Pharmingen, USA). All secondary antibodies were from Jackson ImmunoResearch (USA). For quantification of Mad1 protein we performed Western blots using anti-Mad1 antibodies and quantified the Mad1 bands using the Image Gauge software. Signal data were normalized for actin bands and a mean value was calculated from four independent experiments.
Flow cytometry
The determination of the DNA content and of the mitotic index was performed as described previously (Vogel et al., 2004a) .
Microscopy
Cells were fixed on polylysine-treated coverslips with 3% p-formaldehyde/PBS and DNA was stained with 1 mg/ml Hoechst to visualize interphase chromatin, mitotic condensed chromosomes, multinuclei or apoptotic nuclei. Photos were taken using a digital CCD Camera (Hamamatsu, Japan).
Determination of mitotic timing
Asynchronously growing cells were grown on coverslips and treated with 200 mM ALLN (Calbiochem, Germany) for up to 3 h to block mitotic progression beyond metaphase. Cells were fixed and DNA was stained as described above.
Determination of apoptosis
Cells were treated with 70 mM monastrol, 100 nM taxol or 150 nM nocodazole for up to 48 h. Apoptosis was determined using the following methods. Apoptotic activation of caspase 3 was measured using Ac-DEVD-AMC as a fluorogenic caspase 3 substrate (Gurtu et al., 1997) . Briefly, whole cells were harvested and incubated in a 96-well dish at 371C in a tissue culture incubator in the presence of 2.5 mM Ac-DEVD-AMC (BD PharMingen). Cleaved substrate was determined as triplicates using a Victor 2 1420 multilabel counter (Wallac Oy, Finland) in 30-min intervals for up to 180 min.
To determine apoptotic DNA laddering chromosomal DNA was isolated essentially as described (Herrmann et al., 1994) with minor modifications. Briefly, attached and floating cells were harvested and extracted twice for 10 min with lysis buffer (50 mM Tris-HCl pH7.5, 20 mM EDTA, 1% NP40, 1% SDS). The pooled supernatants were digested with 1 mg/ml RNase A for 2 h at 371C and with 1 mg/ml proteinase K for 4 h at 561C. The chromosomal DNA was precipitated and separated on a 2% agarose gel and visualized with ethidium bromide.
The apoptotic cleavage product of poly-(ADP-Ribose)-Polymerase (PARP) was determined on Western blots as described using anti-PARP antibodies (BD Pharmingen) and anti-actin antibodies (Sigma) were used as a control.
Chromosome spread analysis
Chromosome spreading was performed essentially as described (Hauf et al., 2003) . Briefly, cells were treated with 150 nM nocodazole for 1, 2 or 6 h. Cells were then harvested by mitotic shake off and hypotonically swollen in 40% RPMI medium/ 60% H 2 O for 10 min at 371C. Cells were fixed in Carnoy´s fixative solution (75% methanol/25% acetic acid) with several changes of the fixative. Cells were dropped onto cooled glass slides and dried at RT. Chromosomes were stained in 5% Giemsa (Sigma) for 10 min, rinsed with water, air dried and mounted.
